Correlation Between Cognition Therapeutics and Zura Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Zura Bio Limited, you can compare the effects of market volatilities on Cognition Therapeutics and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Zura Bio.

Diversification Opportunities for Cognition Therapeutics and Zura Bio

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Cognition and Zura is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Zura Bio go up and down completely randomly.

Pair Corralation between Cognition Therapeutics and Zura Bio

Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Zura Bio. But the stock apears to be less risky and, when comparing its historical volatility, Cognition Therapeutics is 2.62 times less risky than Zura Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Zura Bio Limited is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  816.00  in Zura Bio Limited on August 31, 2024 and sell it today you would lose (511.00) from holding Zura Bio Limited or give up 62.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.15%
ValuesDaily Returns

Cognition Therapeutics  vs.  Zura Bio Limited

 Performance 
       Timeline  
Cognition Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Zura Bio Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Cognition Therapeutics and Zura Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cognition Therapeutics and Zura Bio

The main advantage of trading using opposite Cognition Therapeutics and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.
The idea behind Cognition Therapeutics and Zura Bio Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.